Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effectiveness of 2009 H1N1 vaccines during the 2010–2011 influenza season
2010-021033-30Phase 4Completed
- Sponsor
- Thomas H. Lee Partners
- Start
- Jun 2010
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, open-label trial of Influenza A virus A/California/7/2009 X-181 (H1N1) hemagglutinin antigen (propiolactone inactivated), influenza vaccine and Fluarix in influenza and seasonal influenza (2 arms), sponsored by Thomas H. Lee Partners. Primary endpoint: Occurrence of laboratory-confirmed 2009 H1N1 influenza virus infection. Started Jun 2010; status: completed.
02
Drugs
Influenza A virus A/California/7/2009 X-181 (H1N1) hemagglutinin antigen (propiolactone inactivated)influenza vaccineFluarix
03
Conditions
influenzaseasonal influenza
Beyond the preview
Go deeper on 2010-021033-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-021033-30.